ATC CODE
- L01BA04
INDICATIONS AND NEMLC RECOMMENDATIONS
INDICATIONS AND NEMLC RECOMMENDATIONS 1
INDICATION
- Lung mesothelioma.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Price changes or access programmes.
DATE RATIFIED
- 27 November 2008
INDICATIONS AND NEMLC RECOMMENDATIONS 2
INDICATION
- Non-small cell lung cancer.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Evidence of superior efficacy versus cisplatin/gemcitabine.
- Price reduction.
DATE RATIFIED
- 29 September 2011